Target intelligence / Profile preview

Eosinophil count

Molecular classification
Other (Eosinophil count is a laboratory measurement, not a molecular entity)
01

Overview

**Eosinophil count** refers to a laboratory measurement of the number of eosinophils—a type of white blood cell—in peripheral blood. This value is typically obtained as part of a complete blood count with differential. Eosinophils play roles in immune defense against parasites and are involved in allergic responses and inflammation. An elevated eosinophil count (eosinophilia) can indicate conditions such as allergies, asthma, parasitic or fungal infections, autoimmune diseases, some cancers like leukemia or lymphoma, drug reactions, and other inflammatory disorders[1][5][7]. Low counts may be seen with alcohol intoxication or Cushing disease but are usually not clinically significant unless all white cells are low[1]. The eosinophil count itself is **not** a therapeutic target; rather it serves as an important clinical biomarker for diagnosis and monitoring of underlying diseases. --- **Note:** "Eosinophil count" is **not** a molecule or receptor but rather a quantitative clinical parameter derived from measuring cells in blood. It does *not* represent an actionable biological target such as an enzyme or receptor; therefore most fields above do not apply directly. If you seek information on "eosinophils" themselves—the cell type—or specific molecular targets within eosinophilic pathways (such as interleukin 5 receptor), those would be distinct entries requiring separate structured data[1][3][7].

Other names
Absolute eosinophil countEosinophils (when referring to the cell type, not the test)EOS blood testEosinophilia (refers to high levels, not the test itself)
02

Biomarkers

Eosinophil count is used as a biomarker for various conditions including allergic diseases, parasitic infections, autoimmune disorders, certain cancers (e.g., leukemia), and drug reactions[1][5][7].

Beyond the preview

Go deeper on Eosinophil count.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eosinophil count.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call